Guangdong Kanghua Healthcare Group Co., Ltd. (HKG:3689)
Hong Kong · Delayed Price · Currency is HKD 1.740
0.00 (0.00%)
At close: Nov 10, 2026
HKG:3689 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 582 | 579 | 816 | 655 | 602 | 963 | |
Market Cap Growth | -8.42% | -29.10% | 24.49% | 8.89% | -37.50% | -10.00% |
Enterprise Value | 329 | 118 | 655 | 356 | 406 | 835 |
Last Close Price | 1.74 | 1.55 | 2.01 | 1.61 | 1.48 | 2.37 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.24 | 5.22 | 49.99 | 4.91 | 8.92 | 8.32 |
Forward PE | - | 11.15 | 11.15 | 11.15 | 11.15 | 11.15 |
PS Ratio | 0.25 | 0.26 | 0.37 | 0.29 | 0.29 | 0.40 |
PB Ratio | 0.33 | 0.34 | 0.52 | 0.40 | 0.35 | 0.53 |
P/TBV Ratio | 0.37 | 0.38 | 0.59 | 0.43 | 0.36 | 0.56 |
P/FCF Ratio | 2.28 | 2.22 | 3.97 | 8.12 | 5.01 | 4.84 |
P/OCF Ratio | 1.79 | 1.84 | 2.74 | 2.91 | 2.40 | 2.35 |
PEG Ratio | - | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.14 | 0.05 | 0.30 | 0.16 | 0.20 | 0.35 |
EV/EBITDA Ratio | 0.88 | 0.43 | 4.16 | 1.42 | 2.52 | 2.84 |
EV/EBIT Ratio | 1.82 | 0.72 | 15.24 | 2.71 | 12.29 | 5.40 |
EV/FCF Ratio | 1.29 | 0.45 | 3.19 | 4.41 | 3.38 | 4.19 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.31 | 0.21 | 0.31 | 0.28 | 0.30 | 0.37 |
Debt / EBITDA Ratio | 1.41 | 1.14 | 2.38 | 1.62 | 2.55 | 1.98 |
Debt / FCF Ratio | 2.09 | 1.39 | 2.36 | 5.82 | 4.30 | 3.36 |
Net Debt / Equity Ratio | -0.15 | -0.27 | -0.15 | -0.19 | -0.20 | -0.15 |
Net Debt / EBITDA Ratio | -0.90 | -1.70 | -1.51 | -1.28 | -2.08 | -0.94 |
Net Debt / FCF Ratio | -1.06 | -1.77 | -1.16 | -3.98 | -2.80 | -1.39 |
Asset Turnover | 0.70 | 0.75 | 0.77 | 0.76 | 0.68 | 0.76 |
Inventory Turnover | 23.28 | 24.25 | 25.05 | 21.14 | 18.75 | 23.16 |
Quick Ratio | 1.02 | 1.25 | 1.12 | 1.32 | 1.22 | 1.32 |
Current Ratio | 1.10 | 1.35 | 1.27 | 1.43 | 1.35 | 1.45 |
Return on Equity (ROE) | 6.59% | 6.33% | 0.71% | 6.04% | 1.76% | 4.64% |
Return on Assets (ROA) | 3.57% | 3.40% | 0.94% | 2.79% | 0.67% | 3.05% |
Return on Invested Capital (ROIC) | 8.98% | 8.34% | 0.55% | 5.84% | 0.90% | 5.11% |
Return on Capital Employed (ROCE) | 8.50% | 7.90% | 2.20% | 6.40% | 1.60% | 6.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 19.10% | 19.16% | 2.00% | 20.35% | 11.21% | 12.02% |
FCF Yield | 43.95% | 45.11% | 25.19% | 12.32% | 19.95% | 20.67% |
Dividend Yield | 10.73% | 10.29% | 6.54% | - | - | - |
Payout Ratio | 51.75% | 50.01% | - | - | - | - |
Total Shareholder Return | 10.73% | 10.29% | 6.54% | - | - | - |